DescriptionCurator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/13912270
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/13912270
Isoniazid pyruvate is a metabolite of isoniazid. Isoniazid (Laniazid, Nydrazid), also known as isonicotinylhydrazine (INH), is an organic compound that is the first-line medication in prevention and treatment of tuberculosis. It has been claimed that isoniazone pyruvate causes less excretion of pyridoxine than isoniazid and might therefore be less likely to cause peripheral neuritis.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A comparative study of the metabolism and toxicity of isoniazid and isoniazone calcium pyruvate. | 1962 Mar |
|
| [STUDIES ON THE PHYSICOCHEMICAL PROPERTIES OF CALCIUM PYRUVATE ISONIAZONE. VIII. ON THE DISTRIBUTION EQUILIBRIUM OF ISONIAZIDE DERIVATIVES]. | 1963 Aug |
|
| Synthesis and characterization of pyruvate-isoniazid analogs and their copper complexes as potential ICL inhibitors. | 2012 May 1 |
|
| Isocitrate lyase: a potential target for anti-tubercular drugs. | 2013 May |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
14123
Created by
admin on Sat Dec 16 15:19:32 GMT 2023 , Edited by admin on Sat Dec 16 15:19:32 GMT 2023
|
PRIMARY | |||
|
97221
Created by
admin on Sat Dec 16 15:19:32 GMT 2023 , Edited by admin on Sat Dec 16 15:19:32 GMT 2023
|
PRIMARY | |||
|
1081-50-1
Created by
admin on Sat Dec 16 15:19:32 GMT 2023 , Edited by admin on Sat Dec 16 15:19:32 GMT 2023
|
PRIMARY | |||
|
5J3GMG27SA
Created by
admin on Sat Dec 16 15:19:32 GMT 2023 , Edited by admin on Sat Dec 16 15:19:32 GMT 2023
|
PRIMARY | |||
|
DTXSID1057618
Created by
admin on Sat Dec 16 15:19:32 GMT 2023 , Edited by admin on Sat Dec 16 15:19:32 GMT 2023
|
PRIMARY |
All of the following components must be present:
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
